Heavy periods keeping you up? simple pad swap might help you sleep
NCT ID NCT05722444
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a standardized nighttime pad and avoiding leak-prevention behaviors (like waking up early) could improve sleep in 25 women with heavy menstrual bleeding. Participants tracked their sleep quality over three cycles using a standard questionnaire. The goal was to see if a simple product and behavior change could lead to better rest.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- standardized nighttime feminine product
- What this could lead to
- If successful, this could lead to simple, non-drug recommendations to help women with heavy periods sleep better.
- What could go wrong
- This is a very small, completed study (25 people) with no blinding or control group, so results may not apply widely. The intervention is a product and behavior change, not a treatment for heavy bleeding itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
25 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18-50 years old * Generally healthy (self-assessed; no significant underlying disease) * Premenopausal patients with regular menstrual cycles every 21 to 35 days * Patients with at least 3 days and no more than 7 days of bleeding during menstruation * An intact uterus and at least one ovary * Ability and willingness to provide written informed consent * Willingness to adhere to study procedures * Menstrual pads are the primary form for nighttime menstrual protection needs * Will maintain a daily schedule that allows normal or typical sleep habits (ie, not a night-shift worker; \>5 hours of sleep). * Women will self-report that they have heavy flow and perform at least one of the following compensatory behaviors: * Set an alarm or plan to get up in the middle of the night to check or change the pad * Add additional disposable absorbent products for extra leak protection of coverage (e.g. extra pads or liners) * Use pillows or other means to limit sleep positions (to prevent moving at night) * Use something extra on top of my bedding (such as a towel) to sleep on * Wear an extra pair of pants/shorts * Wear tighter clothing than they typically would, like yoga pants Exclusion Criteria: * Currently pregnant or intending to imminently attempt pregnancy * Any condition (social or medical) that, in the opinion of the primary care giver or study staff, would make trial participation unsafe or complicate data interpretation * Difficult sleeping environment due to: * Frequently involved in activities requiring nighttime awakenings (eg, taking care of an infant or loved one). * Disruptive bed partners (i.e., snoring, children, pets, etc) * Diagnosed sleep disorders (i.e. insomnia, sleep apnea, restless leg disorder, breathing disorder, etc) * Use of an Intrauterine Device (IUDs) unless copper IUD. * Regular use (\>1 day per week) of sleep aids and/or sedating medications, including over the counter products like melatonin.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Menstruation; heavy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Dermatology, Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States